The FINEARTS-HF trial provides the first definite evidence that an MRA is beneficial in HFmrEF/HFpEF, explained principal investigator Scott Solomon , MD, senior physician and director of Noninvasive Cardiology, and Senior Physician at Brigham and Women's Hospital
suitable for all skin types
Bundling strategies for complementary products in a horizontal supply chain
Full panels including TSH, free T4, and free T3 are recommended
GLP-1 receptor agonists suppress appetite, and if a breastfeeding mother does not consume enough calories (approximately 450 to 500 extra daily), milk production can decline
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance